Table 3.

Self-reported generic (EQ-5D) and dermatology-specific (Skindex-17) health-related quality of life in patients with and without cutaneous adverse events associated with DMT

	Cutaneous adverse events
	Yes (n = 156)	No (n = 73)	P value*
Generic quality of life
EQ-5D utility
median (IQR)	0.727 (0.620–0.848)	0.718 (0.664–0.814)	0.779
mean (SD)	0.725 (0.205)	0.714 (0.218)
EQ-5D VAS
median (IQR)	70.0 (60.0–80.0)	75.0 (60.0–80.5)	0.361
mean (SD)	67.3 (20.9)	71.7 (15.8)
Dermatology-specific quality of life
Skindex-17 Psychosocial
median (IQR)	1 (0–3)	0 (0–1)	P < 0.001
mean (SD)	2.2 (3.0)	1.0 (2.2)
Skindex-17 Symptoms
median (IQR)	2 (1–3)	1 (0–2)	0.002
mean (SD)	2.1 (1.7)	1.5 (1.5)

*Differences between patients with and without cutaneous adverse events were tested with the Chi square test.